These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34304793)

  • 1. Psychopharmacologic Therapies for Irritable Bowel Syndrome.
    Törnblom H; Drossman DA
    Gastroenterol Clin North Am; 2021 Sep; 50(3):655-669. PubMed ID: 34304793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When.
    Hanna-Jairala I; Drossman DA
    Am J Gastroenterol; 2024 Jul; 119(7):1272-1284. PubMed ID: 38595149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of soluble fibre, antispasmodic drugs, and gut-brain neuromodulators in irritable bowel syndrome: a systematic review and network meta-analysis.
    Black CJ; Yuan Y; Selinger CP; Camilleri M; Quigley EMM; Moayyedi P; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Feb; 5(2):117-131. PubMed ID: 31859183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressants in the treatment of irritable bowel syndrome and visceral pain syndromes.
    Crowell MD; Jones MP; Harris LA; Dineen TN; Schettler VA; Olden KW
    Curr Opin Investig Drugs; 2004 Jul; 5(7):736-42. PubMed ID: 15298070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Open-Label Pilot Study of Duloxetine in Patients With Irritable Bowel Syndrome and Comorbid Major Depressive Disorder.
    Lewis-Fernández R; Lam P; Lucak S; Galfalvy H; Jackson E; Fried J; Rosario M; de la Cruz AA; Sánchez-Lacay A; Díaz S; Schneier F
    J Clin Psychopharmacol; 2016 Dec; 36(6):710-715. PubMed ID: 27755218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotics as a possible treatment option for irritable bowel syndrome.
    Pae CU; Lee SJ; Han C; Patkar AA; Masand PS
    Expert Opin Investig Drugs; 2013 May; 22(5):565-72. PubMed ID: 23506326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
    Thomas RH; Luthin DR
    Pharmacotherapy; 2015 Jun; 35(6):613-30. PubMed ID: 26016701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating Chronic Abdominal Pain in Patients with Chronic Abdominal Pain and/or Irritable Bowel Syndrome.
    Stemboroski L; Schey R
    Gastroenterol Clin North Am; 2020 Sep; 49(3):607-621. PubMed ID: 32718573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
    Cremonini F; Talley NJ
    Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in pharmacological treatment of irritable bowel syndrome.
    Lazaraki G; Chatzimavroudis G; Katsinelos P
    World J Gastroenterol; 2014 Jul; 20(27):8867-85. PubMed ID: 25083060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of psychotropic drugs in irritable bowel syndrome.
    Dekel R; Drossman DA; Sperber AD
    Expert Opin Investig Drugs; 2013 Mar; 22(3):329-39. PubMed ID: 23316916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing pain in irritable bowel syndrome: current perspectives and best practice.
    Algera J; Lövdahl J; Sjölund J; Tornkvist NT; Törnblom H
    Expert Rev Gastroenterol Hepatol; 2023; 17(9):871-881. PubMed ID: 37552616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic abdominal pain in irritable bowel syndrome - current and future therapies.
    Zielińska A; Sałaga M; Włodarczyk M; Fichna J
    Expert Rev Clin Pharmacol; 2018 Jul; 11(7):729-739. PubMed ID: 29957084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging pharmacological therapies for the irritable bowel syndrome.
    Maneerattanaporn M; Chang L; Chey WD
    Gastroenterol Clin North Am; 2011 Mar; 40(1):223-43. PubMed ID: 21333909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of abdominal pain in irritable bowel syndrome.
    Vanuytsel T; Tack JF; Boeckxstaens GE
    J Gastroenterol; 2014 Aug; 49(8):1193-205. PubMed ID: 24845149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using the Rome IV Criteria to Help Manage the Complex IBS Patient.
    Lin LD; Chang L
    Am J Gastroenterol; 2018 Apr; 113(4):453-456. PubMed ID: 29257142
    [No Abstract]   [Full Text] [Related]  

  • 18. Dietary and pharmacological treatment of abdominal pain in IBS.
    Camilleri M; Boeckxstaens G
    Gut; 2017 May; 66(5):966-974. PubMed ID: 28232472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buspirone in the management of refractory irritable bowel syndrome: A case report.
    Karim MA; Al-Baz N; Haddad PM; Reagu SM; Alabdulla M
    Medicine (Baltimore); 2021 Dec; 100(51):e28003. PubMed ID: 34941040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of harm in the pharmacotherapy of irritable bowel syndrome.
    Shah E; Kim S; Chong K; Lembo A; Pimentel M
    Am J Med; 2012 Apr; 125(4):381-93. PubMed ID: 22444104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.